These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 15322953)

  • 1. European clinical guidelines for hyperkinetic disorder -- first upgrade.
    Taylor E; Döpfner M; Sergeant J; Asherson P; Banaschewski T; Buitelaar J; Coghill D; Danckaerts M; Rothenberger A; Sonuga-Barke E; Steinhausen HC; Zuddas A
    Eur Child Adolesc Psychiatry; 2004; 13 Suppl 1():I7-30. PubMed ID: 15322953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marker gene polymorphisms in hyperkinetic disorder--predictors of clinical response to treatment with methylphenidate?
    Seeger G; Schloss P; Schmidt MH
    Neurosci Lett; 2001 Nov; 313(1-2):45-8. PubMed ID: 11684336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive utility of childhood diagnosis of ICD-10 hyperkinetic disorder: adult outcomes in the MTA and effect of comorbidity.
    Arnold LE; Roy A; Taylor E; Hechtman L; Sibley M; Swanson JM; Mitchell JT; Molina BSG; Rohde LA
    Eur Child Adolesc Psychiatry; 2019 Apr; 28(4):557-570. PubMed ID: 30232561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic basis of attention deficit and hyperactivity.
    Thapar A; Holmes J; Poulton K; Harrington R
    Br J Psychiatry; 1999 Feb; 174():105-11. PubMed ID: 10211163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EUNETHYDIS -- searching for valid aetiological candidates of Attention-Deficit Hyperactivity Disorder or Hyperkinetic Disorder.
    Sergeant J
    Eur Child Adolesc Psychiatry; 2004; 13 Suppl 1():I43-9. PubMed ID: 15322956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical guidelines for hyperkinetic disorder. European Society for Child and Adolescent Psychiatry.
    Taylor E; Sergeant J; Doepfner M; Gunning B; Overmeyer S; Möbius HJ; Eisert HG
    Eur Child Adolesc Psychiatry; 1998 Dec; 7(4):184-200. PubMed ID: 9879841
    [No Abstract]   [Full Text] [Related]  

  • 7. The quality of life of children and adolescents with ADHD undergoing outpatient psychiatric treatment: simple disorders of activity and attention and hyperkinetic conduct disorders in comparison with each other and with other diagnostic groups.
    Remschmidt H; Mattejat F
    Atten Defic Hyperact Disord; 2010 Dec; 2(4):161-70. PubMed ID: 21432603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts on the neurobiology of Attention-Deficit/Hyperactivity Disorder.
    Biederman J; Faraone SV
    J Atten Disord; 2002; 6 Suppl 1():S7-16. PubMed ID: 12685515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter genotype and methylphenidate dose response in children with ADHD.
    Stein MA; Waldman ID; Sarampote CS; Seymour KE; Robb AS; Conlon C; Kim SJ; Cook EH
    Neuropsychopharmacology; 2005 Jul; 30(7):1374-82. PubMed ID: 15827573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DSM-IV and ICD-10: a comparison of the correlates of ADHD and hyperkinetic disorder.
    Tripp G; Luk SL; Schaughency EA; Singh R
    J Am Acad Child Adolesc Psychiatry; 1999 Feb; 38(2):156-64. PubMed ID: 9951214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).
    Vles JS; Feron FJ; Hendriksen JG; Jolles J; van Kroonenburgh MJ; Weber WE
    Neuropediatrics; 2003 Apr; 34(2):77-80. PubMed ID: 12776228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention deficit hyperactivity disorder: unravelling the molecular genetics.
    Thapar A
    Mol Psychiatry; 1998 Sep; 3(5):370-2. PubMed ID: 9774767
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of the biological bases of ADHD: what have we learned from imaging studies?
    Durston S
    Ment Retard Dev Disabil Res Rev; 2003; 9(3):184-95. PubMed ID: 12953298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention-deficit/hyperactivity disorder or hyperactivity in preschool children.
    Thompson M
    Br J Hosp Med (Lond); 2007 Jul; 68(7):356-9. PubMed ID: 17663305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.
    Kustanovich V; Ishii J; Crawford L; Yang M; McGough JJ; McCracken JT; Smalley SL; Nelson SF
    Mol Psychiatry; 2004 Jul; 9(7):711-7. PubMed ID: 14699430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tic disorders].
    Hebebrand J; Rothenberger A
    Z Kinder Jugendpsychiatr Psychother; 2009 Jul; 37(4):360-4. PubMed ID: 20306809
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictive validity of DSM-IV and ICD-10 criteria for ADHD and hyperkinetic disorder.
    Lee SI; Schachar RJ; Chen SX; Ornstein TJ; Charach A; Barr C; Ickowicz A
    J Child Psychol Psychiatry; 2008 Jan; 49(1):70-8. PubMed ID: 17979965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention deficit/hyperactivity disorder: a review and update.
    Cormier E
    J Pediatr Nurs; 2008 Oct; 23(5):345-57. PubMed ID: 18804015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is OPTAx useful for monitoring the effect of stimulants on hyperactivity and inattention? A brief report.
    Tabori-Kraft J; Sørensen MJ; Kaergaard M; Dalsgaard S; Thomsen PH
    Eur Child Adolesc Psychiatry; 2007 Aug; 16(5):347-51. PubMed ID: 17476552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.